GRPR-Antagonists Carrying DOTAGA-Chelator via Positively Charged Linkers: Perspectives for Prostate Cancer Theranostics
Gastrin-releasing peptide receptor (GRPR)-antagonists have served as motifs in the development of theranostic radioligands for prostate cancer. Our efforts have been focused on the development of radiolabeled RM26 (H-DPhe<sup>6</sup>-Gln<sup>7</sup>-Trp<sup>8</sup>...
Saved in:
Main Authors: | Karim Obeid (Author), Panagiotis Kanellopoulos (Author), Ayman Abouzayed (Author), Adam Mattsson (Author), Vladimir Tolmachev (Author), Berthold A. Nock (Author), Theodosia Maina (Author), Anna Orlova (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncology
by: Panagiotis Kanellopoulos, et al.
Published: (2024) -
Peptide Radioligands in Cancer Theranostics: Agonists and Antagonists
by: Berthold A. Nock, et al.
Published: (2023) -
Synthesis and Preclinical Evaluation of Radio-Iodinated GRPR/PSMA Bispecific Heterodimers for the Theranostics Application in Prostate Cancer
by: Ayman Abouzayed, et al.
Published: (2019) -
Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer-Optimization of the Affinity towards PSMA by Linker Modification in Murine Model
by: Fanny Lundmark, et al.
Published: (2020) -
Localization of <sup>99m</sup>Tc-GRP Analogs in GRPR-Expressing Tumors: Effects of Peptide Length and Neprilysin Inhibition on Biological Responses
by: Aikaterini Kaloudi, et al.
Published: (2019)